Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

For the first time in prostate cancer this study demonstrates the importance of integrated genomic analyses incorporating both benign and tumour tissue data in identifying molecular alterations leading to the generation of robust gene sets that are predictive of clinical outcome in independent patient cohorts.